Brian Rini
Impact in
-
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
-
- Renal cell carcinoma treatment
Papers in
-
- Renal cell carcinoma treatment 6
- Prostate Cancer Treatment and Research 2
- Oncology 4
- CAR-T cell therapy research 2
- Co-authors
- Robert L. Wollmann (2 shared papers)Jonathan S. Citow (2 shared papers)R. Loch Macdonald (2 shared papers)Bernard Escudier (2 shared papers)Cezary Szczylik (1 shared paper)Mayer Fishman (1 shared paper)Nizar M. Tannir (1 shared paper)Yu‐Nien Sun (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Future Oncology (2 papers)Neurosurgery (2 papers)Cancer (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United StatesFrancePoland
In The Last Decade
Brian Rini
14 papers receiving 246 citations
Peers
Comparison fields: 5 of 45
- Cancer Research 80
- Pulmonary and Respiratory Medicine 88
- Oncology 70
- Endocrinology, Diabetes and Metabolism 32
- Pathology and Forensic Medicine 29
Countries citing papers authored by Brian Rini
This map shows the geographic impact of Brian Rini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Rini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Rini more than expected).
Fields of papers citing papers by Brian Rini
This network shows the impact of papers produced by Brian Rini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Rini. The network helps show where Brian Rini may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Rini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 87 | |
| 2 | 2020 | 34 | |
| 3 | 2001 | 31 | |
| 4 | 2016 | 30 | |
| 5 | 2017 | 14 | |
| 6 | 2013 | 13 | |
| 7 | 2018 | 11 | |
| 8 | 2018 | 8 | |
| 9 | 2016 | 7 | |
| 10 | 2007 | 5 | |
| 11 | 2012 | 2 | |
| 12 | 2014 | 2 | |
| 13 | 2010 | 1 | |
| 14 | 2001 | 1 |
About Brian Rini
Brian Rini is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Surgery, having authored 14 papers that have together received 246 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (6 papers), Renal and related cancers (3 papers), Cancer Genomics and Diagnostics (2 papers), Prostate Cancer Treatment and Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Cancer, Lipids, and Metabolism (2 papers), CAR-T cell therapy research (2 papers) and CNS Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (80 citations), Pulmonary and Respiratory Medicine (88 citations), Oncology (70 citations), Endocrinology, Diabetes and Metabolism (32 citations) and Pathology and Forensic Medicine (29 citations). Brian Rini has collaborated with scholars based in United States, France and Poland. Frequent co-authors include Robert L. Wollmann, Jonathan S. Citow, R. Loch Macdonald, Bernard Escudier, Cezary Szczylik, Mayer Fishman, Nizar M. Tannir, Yu‐Nien Sun, Piotr Tomczak and Alain Ravaud. Their work appears in journals such as Journal of Clinical Oncology, Future Oncology, Neurosurgery, Cancer and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.